These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36763506)

  • 1. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
    Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
    Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction.
    Kanashiro-Takeuchi RM; Takeuchi LM; Dulce RA; Kazmierczak K; Balkan W; Cai R; Sha W; Schally AV; Hare JM
    Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H739-H750. PubMed ID: 36897749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine Model.
    LaPenna KB; Li Z; Doiron JE; Sharp TE; Xia H; Moles K; Koul K; Wang JS; Polhemus DJ; Goodchild TT; Patel RB; Shah SJ; Lefer DJ
    J Am Heart Assoc; 2023 Feb; 12(4):e028480. PubMed ID: 36752224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.
    Withaar C; Meems LMG; Markousis-Mavrogenis G; Boogerd CJ; Silljé HHW; Schouten EM; Dokter MM; Voors AA; Westenbrink BD; Lam CSP; de Boer RA
    Cardiovasc Res; 2021 Jul; 117(9):2108-2124. PubMed ID: 32871009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
    Wu H; Tang LX; Wang XM; Li LP; Chen XK; He YJ; Yang DZ; Shi Y; Shou JL; Zhang ZS; Wang L; Lu BJ; An SM; Zeng CY; Wang WE
    Acta Pharmacol Sin; 2023 Jun; 44(6):1149-1160. PubMed ID: 36473990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
    Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ovary-intact menopause in a mouse model of heart failure with preserved ejection fraction.
    Troy AM; Normukhamedova D; Grothe D; Momen A; Zhou YQ; McFadden M; Hussain M; Billia F; Cheng HM
    Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H522-H537. PubMed ID: 38180450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension.
    Berger JH; Shi Y; Matsuura TR; Batmanov K; Chen X; Tam K; Marshall M; Kue R; Patel J; Taing R; Callaway R; Griffin J; Kovacs A; Shanthappa DH; Miller R; Zhang BB; Roth Flach RJ; Kelly DP
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of Jiming Powder in ameliorating heart failure with preserved ejection fraction based on metabolomics].
    Wei XQ; Fan XY; Pu HY; Li S; Tang JY; Gao K; Li FH; Yu X; Guo SZ
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(17):4747-4760. PubMed ID: 37802814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways.
    Dawuti A; Sun S; Wang R; Gong D; Liu R; Kong D; Yuan T; Zhou J; Lu Y; Wang S; Du G; Fang L
    Biomed Pharmacother; 2023 Dec; 168():115837. PubMed ID: 37931518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.
    Ni XY; Feng XJ; Wang ZH; Zhang Y; Little PJ; Cao Y; Xu SW; Tang LQ; Weng JP
    Acta Pharmacol Sin; 2024 Aug; 45(8):1604-1617. PubMed ID: 38589689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac reverse remodeling in a mouse model with many phenotypical features of heart failure with preserved ejection fraction: effects of modifying lifestyle.
    Aidara ML; Walsh-Wilkinson É; Thibodeau SÈ; Labbé EA; Morin-Grandmont A; Gagnon G; Boudreau DK; Arsenault M; Bossé Y; Couët J
    Am J Physiol Heart Circ Physiol; 2024 Apr; 326(4):H1017-H1036. PubMed ID: 38363584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.
    Cochran JD; Yura Y; Thel MC; Doviak H; Polizio AH; Arai Y; Arai Y; Horitani K; Park E; Chavkin NW; Kour A; Sano S; Mahajan N; Evans M; Huba M; Naya NM; Sun H; Ban YH; Hirschi KK; Toldo S; Abbate A; Druley TE; Ruberg FL; Maurer MS; Ezekowitz JA; Dyck JRB; Walsh K
    Circulation; 2023 Oct; 148(15):1165-1178. PubMed ID: 37681311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen sulfide alleviates heart failure with preserved ejection fraction in mice by targeting mitochondrial abnormalities via PGC-1α.
    Huang S; Chen X; Pan J; Zhang H; Ke J; Gao L; Yu Chang AC; Zhang J; Zhang H
    Nitric Oxide; 2023 Jul; 136-137():12-23. PubMed ID: 37182786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling.
    Marunouchi T; Matsumura K; Fuji E; Iwamoto A; Tanonaka K
    Pharmacology; 2024; 109(1):43-51. PubMed ID: 38016432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating β-Hydroxybutyrate-activated Citrate Synthase.
    Zhang X; Wang N; Fu P; An Y; Sun F; Wang C; Han X; Zhang Y; Yu X; Liu Y
    J Cardiovasc Pharmacol; 2023 Nov; 82(5):375-388. PubMed ID: 37643027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
    Hohendanner F; Bode D; Primessnig U; Guthof T; Doerr R; Jeuthe S; Reimers S; Zhang K; Bach D; Wakula P; Pieske BM; Heinzel FR
    J Mol Cell Cardiol; 2018 Feb; 115():10-19. PubMed ID: 29289652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
    Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.